Cynthia Smith's Net Worth
$1.75 Million
Who is Cynthia Smith?
Cynthia Smith has an estimated net worth of $1.75 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, ZS Pharma, Inc., Nivalis Therapeutics, Inc., Spero Therapeutics, Inc., Protara Therapeutics, Inc., Akebia Therapeutics, Inc., and AGIOS PHARMACEUTICALS, INC..
SEC CIK
Cynthia Smith's CIK is 0001609480
Past Insider Trading and Trends
2021 was Cynthia Smith's most active year for acquiring shares with 10 total transactions. Cynthia Smith's most active month to acquire stocks was the month of May. 2015 was Cynthia Smith's most active year for disposing of shares, totalling 9 transactions. Cynthia Smith's most active month to dispose stocks was the month of November. 2015 saw Cynthia Smith paying a total of $1,037,754.80 for 29,030 shares, this is the most they've acquired in one year. In 2015 Cynthia Smith cashed out on 282,919 shares for a total of $1,133,820.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.33K |
$38.25 | -$127,487.25 |
0
|
Dec 28
| |||
Form 4
|
∞
| 3.33K |
—
|
—
| 3.33K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ZS Pharma, Inc. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.60K |
$90.00 | -$1,133,820.00 |
0
|
Dec 17
| |||
Form 4
|
∞
| 9.15K |
$10.92 | $100,011.05 | 9.15K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nivalis Therapeutics, Inc. (ALPN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.3101
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +57.14% | 20K |
—
|
—
| 55K |
May 29
| |||
Form 4
| +133.33% | 20K |
—
|
—
| 35K |
Oct 5
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Protara Therapeutics, Inc. (TARA) Snapshot price: $1.9505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |